Gara Jalqabaatti › Myeloma Baay’ee › New Mexico

Qorannoo klinikaalii Myeloma Baay’ee New Mexico keessatti

Qorannoo 5 Myeloma Baay’ee f New Mexico keessatti hirmaatuu jiru.

Takkalaa qorannoo (Ingiliffa)

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Christus St. Vincent Regional Cancer Center, Santa Fe

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07518186

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Christus St. Vincent Regional Cancer Center, Santa Fe

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05552222

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lovelace Medical Center - Saint Joseph Square, Albuquerque
Presbyterian Kaseman Hospital, Albuquerque
The University of New Mexico Comprehensive Cancer Center, Albuquerque
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

GSK Investigational Site, Farmington

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07227311

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Lovelace Medical Center-Saint Joseph Square, Albuquerque
University of New Mexico Cancer Center, Albuquerque
Presbyterian Kaseman Hospital, Albuquerque
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin hundi · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT05561387

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.